Class IIITerminatedD-0857-2018
Drug recall · May 30, 2018
Lidocaine Patch 5% recall
Why: Failed Stability Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)
- Lots / codes
Carton Lot Number:1147020B Patch (Envelope) Lot Number: 1147020
- Quantity
- 30,382 patches
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- United States
- Initiated
- April 30, 2018 · Voluntary: Firm initiated
- Classified
- June 11, 2018
- Reported
- May 30, 2018
- Ended
- January 14, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.